Cipla receives EIR from USFDA
Cipla receives EIR from USFDA

Cipla receives EIR from USFDA

Amir Shaikh Article rating: 2.5

Cipla today informed the bourses that it has received an Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA), indicating the closure of the inspection at Invagen (US) manufacturing facility

Alembic Pharma gets USFDA nod for Azithromycin tablets
Alembic Pharma gets USFDA nod for Azithromycin tablets

Alembic Pharma gets USFDA nod for Azithromycin tablets

Nidhi Jani Article rating: 5.0

Azithromycin tablets are used to treat different types of infections caused by bacteria, such as respiratory, skin, ear and eye infections. Alembic has a cumulative total of 115 ANDA approvals (103 final approvals and 12 tentative approvals) from USFDA.

Burger King India gets SEBI nod for IPO
Burger King India gets SEBI nod for IPO

Burger King India gets SEBI nod for IPO

Rishikesh Gaikwad Article rating: 2.7
Burger King India Ltd, the national master franchisee of American burger brand in India, has received a green signal from Securities and Exchange Board of India (SEBI) to float its Initial Public Offering (IPO).

Index trend and stocks in action on January 28, 2020
Index trend and stocks in action on January 28, 2020

Index trend and stocks in action on January 28, 2020

Karan Dsij Article rating: 4.3

January 9 gap area is likely to be an important support to watch out and on the upside, the level of the zone of 12,230-12,280 is likely to act as a resistance in the short-term. Stocks in news: Prakash Industries, Cholamandalam Investment and Finance Company, Maruti Suzuki India, Adani Gas, GHCL.

Weakness to continue as sentiments get hit by Coronavirus
Weakness to continue as sentiments get hit by Coronavirus

Weakness to continue as sentiments get hit by Coronavirus

Karan Dsij Article rating: 4.3

Indian markets are likely to extend their losses as the global weakness is sure to spill on the Indian shores as well. SGX Nifty, which is currently trading almost 20 points below its yesterday’s close, is already reflecting it.

Top reasons people give to ignore financial planners
Top reasons people give to ignore financial planners

Top reasons people give to ignore financial planners

Henil Shah Article rating: 4.5

Financial planning is a very essential thing one should consider doing. However, when financial advisers approach people, they come up with random reasons to avoid financial planning. Let’s find out what are the excuses people make in order to skip financial planning!

Lupin gains on UKMHRA observation
Lupin gains on UKMHRA observation

Lupin gains on UKMHRA observation

Geyatee Deshpande Article rating: 3.5

Lupin Limited, which is a popular pharmaceutical company, announced about their successful completion of inspection undertaken by UK Medicines and Healthcare Products Regulatory Agency (UKMHRA).

Quarterly results to watch out on January 28
Quarterly results to watch out on January 28

Quarterly results to watch out on January 28

Geyatee Deshpande Article rating: 5.0

The following stocks will be in focus during Tuesday’s trading session in the light of their result announcements: Subros, Maruti Suzuki, JK Lakshmi Cement, Cummins India and Century Textiles & Industries.

JSW Ventures set to mark first close of new VC fund
JSW Ventures set to mark first close of new VC fund

JSW Ventures set to mark first close of new VC fund

Rishikesh Gaikwad Article rating: 3.8
JSW Ventures, the venture capital arm of billionaire Sajjan Jindal‎-led JSW Group, is set to make the first close of its second fund that seeks to raise a total of Rs 350 crore ($50 million)
RSS
First22742275227622772279228122822283Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR